Description
Abiron, branded internationally as Zytiga, is a beacon of hope for individuals battling metastatic castration-resistant prostate cancer (mCRPC). Each tablet of Abiron contains 250 mg of the active substance Abiraterone Acetate, meticulously formulated to inhibit androgen production, offering patients a chance to prolong survival and improve quality of life. Manufactured by BDR Pharmaceuticals Int’l Pvt Ltd., Abiron embodies excellence in cancer care, providing patients and healthcare providers with a reliable ally in the fight against prostate cancer.
Key Features:
- Targeted Cancer Treatment: Abiron, with its active ingredient Abiraterone Acetate, targets and inhibits the production of androgens, which fuel the growth of prostate cancer cells. By disrupting the tumor microenvironment, Abiron helps slow disease progression and extend survival in patients with mCRPC.
- Prolonged Survival and Quality of Life: Clinical studies have demonstrated the efficacy of Abiron in prolonging overall survival and delaying disease progression in patients with metastatic prostate cancer. By reducing tumor burden and alleviating symptoms, Abiron improves quality of life and offers patients valuable time with their loved ones.
- Convenient Dosage Form: Each pack of Abiron contains 120 tablets, each tablet containing 250 mg of Abiraterone Acetate. This convenient dosage form allows for easy administration and ensures patients have an ample supply of medication to support their treatment regimen.
- Prescription Required: As a potent cancer therapy, Abiron requires a prescription from a qualified healthcare professional. This ensures that patients receive appropriate medical guidance and monitoring throughout their treatment journey.
- Quality Assurance: Manufactured by BDR Pharmaceuticals Int’l Pvt Ltd., Abiron undergoes stringent quality control measures to ensure purity, potency, and safety. Each tablet is meticulously inspected to uphold the highest standards of pharmaceutical excellence, providing patients and healthcare providers with confidence in their medication.
Experience the transformative potential of Abiron and embrace hope and confidence in the fight against metastatic castration-resistant prostate cancer. With Abiron by your side, face cancer with resilience and determination. Choose Abiron for targeted cancer treatment and a chance at prolonged survival and improved quality of life.
Reviews
There are no reviews yet.